Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors - A single center experience

Hepato-Gastroenterology

Volumn 59, Issue 120, 2012, Pages 2623-2626

  Tsuchikawa, Takahiro ^a   Hirano, Satoshi ^a   Tanaka, Eiichi ^a   Kato, Kentaro ^a   Matsumoto, Joe ^a   Sichinohe, Toshiaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Curative resection; Liver metastases; Pancreatic neuroendocrine tumors; Prognosis

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; OVERALL SURVIVAL; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; COOPERATIVE BEHAVIOR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; INTERDISCIPLINARY COMMUNICATION; JAPAN; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; ORGANIZATIONAL OBJECTIVES; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATIENT CARE TEAM; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872073388     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12116     Document Type: Article

References (26)

1. O'Grady HL, Conlon KC: Pancreatic neuroendocrine tumors. Eur J Surg Oncol 2008; 34:324-332.
2. Schurr PG, Strate T, Rese K, et al.: Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg 2007; 245:273-281.
3. Falconi M, Bettini R, Boninsegna L, et al.: Surgical strategy in the treatment of pancreatic neuroendocrine tumors. J Pancreas 2006; 7:150-156.
4. Dralle H, Krohn SL, Karges W, et al.: Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg 2004; 28:1248-1260.
5. Frilling A, Li J, Malamutmann E, Schmid KW, et al.: Treatment of liver metastases from neuroendocrine tumors in relation to the extent of hepatic disease. Br J Surg 2009; 96:175-184.
6. WHO: Classification of Tumors of the Digestive System. Eds. Lyons: Bosman FT, 4th ed. 2010; IARC Press.
7. Kazanjian KK, Reber HA, Hines OJ: Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 2006; 141:765-769.
8. Hellman P, Andersson M, Rastad J, et al.: Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 2000; 24:1353-1360.
9. Sarmiento JM, Heywood G, Rubin J, et al.: Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197:29-37.
10. Musunuru S, Chen H, Rajpal S, et al.: Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 2006; 141:1000-1004.
11. Gomez D, Malik HZ, Al-Mukthar A, et al.: Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumors: outcome and prognostic predictors. HPB Oxford. 2007; 9:345-351.
12. Elias D, Lefevre JH, Duvillard P, et al.: Hepatic metastases from neuroendocrine tumors with a "Thin Slice" pathological examination: they are many more than you think. Ann Surg 2010; 251:307-310.
13. Mayo, Skye C, de Jong, Mechteld C, et al.: Surgery versus intraarterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol; 18:3657-3665.
14. Bonney GK, Gomez D, Rahman SH, et al.: Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience. JOP 2008; 9:19-25.
15. Schmitt AM, Anlauf M, Rousson V, et al.: WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 2007; 31:1677-1682.
16. Zhang L, Smyrk TC, Oliveira AM, et al.: KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers. Am J Surg Pathol 2009; 33:1562-1569.
17. Ito H, Abramson M, Ito K, et al.: Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience. J Gastrointest Surg 2010; 14:891-898.
18. Roche A, Girish BV, de Baere T, et al.: Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003; 13:136-140.
19. Baere T, Deschamps F, Teriitheau C, et al.: Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol 2008; 19:855-861.
20. Deshpande V, Fernandez-del Castillo C, et al.: Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 2004; 28:1145-1153.
21. Kawakami H, Kuwatani M, Hirano S, et al.: Pancreatic endocrine tumors with intraductal growth into the main pancreatic duct and tumor thrombus within the portal vein: a case report and review of the literature. Intern Med 2007; 46:273-277.
22. Akatsu T, Aiura K, Shimazu M, et al.: Successful pancreatectomy with en-bloc resection of the celiac artery and portal vein for pancreatic endocrine carcinoma. Hepato-gastroenterol 2007; 54:1269-1271.
23. Rinke A, Müller HH, Schade-Brittinger C, et al.: PROMID Study Group: Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine mid-gut tumors: a report from the PROMID Study Group. J Clin Oncol 2009; 27:4656-4663.
24. Yao JC, Shah MH, Ito T, Bohas CL, et al.: RAD001 in Advanced Neuroendocrine Tumors, Third Trial RADIANT-3. Study Group: Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011; 364:514-523.
25. Yuchen J, Chanjuan S, Barish HE, et al.: DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011; 331:1199-1203.
26. Nasir A, Helm J, Turner L, et al.: A novel predictor of liver metastasis in primary pancreatic endocrine neoplasms. Pancreas 2011; 40:627-633.